EXACT Sciences (NASDAQ:EXAS) Rating Increased to Buy at BTIG Research

Daniel Fowler
May 13, 2018

Palo Alto Ltd Liability invested in 0.7% or 310,876 shares. Geode Capital Management LLC lifted its position in shares of EXACT Sciences by 2.3% in the 4th quarter.

Shares of NASDAQ:EXAS traded up $5.42 during midday trading on Friday, hitting $52.02. 7,584,098 shares of the company were exchanged, compared to its average volume of 2,940,351. Exact Sciences Corporation (NASDAQ:EXAS) has risen 81.43% since April 28, 2017 and is uptrending. It has outperformed by 69.88% the S&P500. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

The stock's price switched up 4.69% 20-Days Simple Moving Average, dropped -1.65% from 50-Days Simple Moving Average and fell -4.44% from 200 Days Simple Moving Average. Florida-based State Board Of Administration Of Florida Retirement System has invested 0.01% in Exact Sciences Corporation (NASDAQ:EXAS). The stock increased 0.56% or $0.55 during the last trading session, reaching $99.33. About 107,221 shares traded. It has outperformed by 8.56% the S&P500. On Monday, November 13 the stock of Exact Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by Leerink Swann. Therefore 75% are positive. Canaccord Genuity maintained the stock with "Buy" rating in Tuesday, October 3 report. On Friday, April 27 Canaccord Genuity maintained Exact Sciences Corporation (NASDAQ:EXAS) with "Buy" rating. On Wednesday, March 28 the firm earned "Buy" rating by Leerink Swann. The firm earned "Buy" rating on Wednesday, May 31 by Canaccord Genuity. Macquarie Research maintained the shares of AXP in report on Thursday, April 21 with "Underperform" rating.

3/29/2018-William Blair Reiterated Rating of Buy. The company presently has an average rating of "Hold" and a consensus price target of $16.73. Six investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company.

Since January 2, 2018, it had 0 insider buys, and 20 selling transactions for $24.73 million activity. In the last 90 days, insiders have sold 229,834 shares of company stock valued at $10,341,366. The stock rating was downgraded by Benchmark to "Hold" on Friday, February 23. Bush James Peter sold 12,789 shares worth $1.27 million.

Investors sentiment decreased to 0.88 in 2017 Q4. At the moment, the company has a debt-to-equity ratio of 0.84, a current ratio of 1.10, and a quick ratio of 0.90.

Shares of NASDAQ:EXAS - EXACT Sciences closed the previous trading session at 52.92 up +6.32 13.56% with 2111475 shares trading hands.

Israel accuses Iranian forces of conducting rocket attack on Golan Heights
Iran's enemies are not seeking military confrontation, said the deputy head of the IRGC, Brigadier Hossein Salami, on Thursday. The diplomat denied Israel's statements that the attacks were not directed against the armed forces of Syria.

Hedge funds have recently added to or reduced their stakes in the business. Ubs Asset Mgmt Americas holds 0.04% or 873,566 shares. Morgan Stanley has invested 0.03% in Exact Sciences Corporation (NASDAQ:EXAS). Salem Investment Counselors Inc. raised its stake in shares of EXACT Sciences by 548.0% in the fourth quarter.

Exact Sciences Corporation (NASDAQ:EXAS) now has a Weekly Volatility of 5.07% percent while its Monthly Volatility is at 5.50% percent. Xact Kapitalforvaltning AB bought a new position in EXACT Sciences during the fourth quarter worth about $606,000. Jpmorgan Chase & invested in 0.03% or 2.72 million shares. Smith Asset Mgmt Gru LP owns 26,370 shares for 0.04% of their portfolio. Solaris Asset Management Limited Liability Com stated it has 0.05% in Exact Sciences Corporation (NASDAQ:EXAS). Jane Street Ltd holds 0% or 19,779 shs in its capital. Institutions purchase large blocks of a company's outstanding shares and can exert considerable influence upon its management.

Exact Sciences Corporation (NASDAQ:EXAS) rose to $52.02. First Mercantile Trust Company has invested 0.33% in Exact Sciences Corporation (NASDAQ:EXAS).

Investors sentiment increased to 1.1 in 2017 Q4. Its up 0.06, from 0.83 in 2017Q3. Following the sale, the director now owns 52,610 shares in the company, valued at $2,090,195.30. 14 funds opened positions while 43 raised stakes. Reilly Fincl Advisors Llc stated it has 1.57% of its portfolio in Abbott Laboratories (NYSE:ABT). Victory Capital Management Inc. now owns 1,189,560 shares of the medical research company's stock worth $62,499,000 after acquiring an additional 539,160 shares during the period. Summit Grp Lc has 323,500 shares. 56,575 are held by Ledyard Bancorp. It also upped Shopify Inc. stake by 24,635 shares and now owns 910,475 shares. Strs Ohio holds 45,500 shares or 0.01% of its portfolio. Ibm Retirement Fund has 0.44% invested in Abbott Laboratories (NYSE:ABT). It was reported on April, 28 by Barchart.com. Acadian Asset Management Limited Liability reported 3,509 shares. Oakworth Capital accumulated 15,600 shares. This's net activity of $24.73 million. 11,106 Abbott Laboratories (NYSE:ABT) shares with value of $667,804 were sold by Fussell Stephen R. Another trade for 996 shares valued at $58,635 was made by Watkin Jared on Wednesday, February 28. Bb&T Securities Ltd Limited Liability Company reported 192,659 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 33% are positive. On Monday, July 10 the stock rating was maintained by BMO Capital Markets with "Hold". The company was downgraded on Thursday, February 25 by Roth Capital. Wood maintained American Express Company (NYSE:AXP) on Thursday, April 21 with "Market Perform" rating. The stock has "Outperform" rating by Robert W. Baird on Tuesday, October 31.

Analyst recommendation for this stock stands at 1.90. The rating was maintained by Bank of America with "Buy" on Thursday, October 19. The stock of Abbott Laboratories (NYSE:ABT) has "Buy" rating given on Saturday, August 29 by Deutsche Bank.

Other reports by

Discuss This Article